Source:http://linkedlifedata.com/resource/pubmed/id/21457884
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
2011-4-4
|
| pubmed:grant | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Apr
|
| pubmed:issn |
1534-4436
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
106
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
342-343.e6
|
| pubmed:meshHeading | |
| pubmed:year |
2011
|
| pubmed:articleTitle |
Total tryptase levels indicate risk for systemic reactions to rush immunotherapy and mast cell activation.
|
| pubmed:publicationType |
Letter,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|